High expression of fibroblast‐activating protein is a prognostic marker in non‐small cell lung carcinoma
Abstract Background Fibroblast‐activating protein (FAP) is expressed in cancer‐associated fibroblasts (CAFs) in many human carcinomas and in some types of carcinoma cells. Here, we examined the proportion of FAP protein expression in non‐small cell lung carcinoma (NSCLC) and investigated the correla...
Main Authors: | Naoki Yanagawa, Mayu Sugai, Shunsuke Shikanai, Ryo Sugimoto, Mitsumasa Osakabe, Noriyuki Uesugi, Hajime Saito, Makoto Maemondo, Tamotsu Sugai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-08-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14579 |
Similar Items
-
Prognostic and predictive value of CD163 expression and the CD163/CD68 expression ratio for response to adjuvant chemotherapy in patients with surgically resected lung squamous cell carcinoma
by: Naoki Yanagawa, et al.
Published: (2023-07-01) -
Expression Patterns of Microenvironmental Factors and Tenascin-C at the Invasive Front of Stage II and III Colorectal Cancer: Novel Tumor Prognostic Markers
by: Mai Hashimoto, et al.
Published: (2021-08-01) -
The Frequency of DNA Mismatch Repair Deficiency Is Very Low in Surgically Resected Lung Carcinoma
by: Naoki Yanagawa, et al.
Published: (2021-10-01) -
Pulmonary epithelial–myoepithelial carcinoma without AKT1, HRAS or PIK3CA mutations: a case report
by: Naoki Yanagawa, et al.
Published: (2020-08-01) -
Genome‐wide analysis of colorectal cancer based on gene‐based somatic copy number alterations during neoplastic progression within the same tumor
by: Shun Yamada, et al.
Published: (2023-02-01)